Pharmacogenetics: A New - or not so New?-Concept in Healthcare
Pharmacogenetics is today widely proclaimed as being about to revolutionize the face of medicine. In a more realistic assessment, the implementation of molecular genetics and biology will continue to provide us, as it has done already, with better ways to diagnose and treat illnesses, but it will do so at a stepwise and evolutionary pace, based on an improved understanding of the nature of disease, allowing more specific treatments, better risk prediction, and the implementation of preventive strategies. As such, future progress in biomedicine will travel the same well-trodden paths of improved differential diagnosis and risk prediction along which it has advanced for the last decades and centuries. So, while meaningful biomedical research today, by and large, depends on the use of the newly developed tools of genetics and genomics, and the insights we gain through them, it is unlikely to fundamentally change the direction of medical progress. Copyright 2003 The International Association for the Study of Insurance Economics.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 28 (2003)
Issue (Month): (04)
|Contact details of provider:|| Postal: Route de Malagnou 53, CH - 1208 Geneva|
Phone: +41-22 707 66 00
Fax: +41-22 736 75 36
Web page: http://www.blackwellpublishing.com/journal.asp?ref=1018-5895
More information through EDIRC
|Order Information:||Web: http://www.blackwellpublishing.com/subs.asp?ref=1018-5895|
When requesting a correction, please mention this item's handle: RePEc:bla:geneva:v:28:y:2003:i::p:316-330. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Wiley-Blackwell Digital Licensing)or (Christopher F. Baum)
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.